Loading...
XHKG2005
Market cap1.31bUSD
Dec 23, Last price  
3.45HKD
1D
2.37%
1Q
-9.92%
Jan 2017
39.68%
IPO
711.76%
Name

SSY Group Ltd

Chart & Performance

D1W1MN
XHKG:2005 chart
P/E
7.74
P/S
1.58
EPS
0.45
Div Yield, %
4.37%
Shrs. gr., 5y
-0.41%
Rev. gr., 5y
9.10%
Revenues
6.46b
+0.45%
847,576,529849,916,765858,323,1461,180,455,3481,591,028,0001,739,628,0001,971,657,0002,155,215,0002,430,684,0002,745,316,0002,091,471,0002,221,921,0002,361,250,0003,076,369,0004,180,787,9994,635,675,0004,260,898,0005,356,763,0006,434,025,0006,463,009,000
Net income
1.32b
+17.44%
102,366,478111,962,68993,115,546123,833,773102,106,000216,095,000260,592,000-41,401,000281,003,000411,814,000602,929,000403,416,000489,535,000664,719,000911,774,0001,136,101,000611,971,000785,533,0001,122,837,0001,318,616,000
CFO
926m
+17.66%
41,197,765136,783,61925,180,00289,490,122142,685,000228,241,000287,807,000171,498,000242,068,000597,922,000307,607,000562,694,000686,484,000552,438,000969,825,000669,355,000527,644,000747,906,000786,824,000925,747,000
Dividend
Sep 12, 20240.08 HKD/sh
Earnings
Mar 25, 2025

Profile

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.
URL
http://www.ssygroup.com.hk/
IPO date
Dec 20, 2005
Employees
5,300
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
6,463,009
0.45%
6,434,025
20.11%
5,356,763
25.72%
Cost of revenue
4,662,776
5,165,906
4,516,661
Unusual Expense (Income)
NOPBT
1,800,233
1,268,119
840,102
NOPBT Margin
27.85%
19.71%
15.68%
Operating Taxes
254,281
209,602
160,104
Tax Rate
14.12%
16.53%
19.06%
NOPAT
1,545,952
1,058,517
679,998
Net income
1,318,616
17.44%
1,122,837
42.94%
785,533
28.36%
Dividends
(445,507)
(388,116)
(302,610)
Dividend yield
3.03%
3.02%
2.48%
Proceeds from repurchase of equity
(32,969)
(89,089)
(191,559)
BB yield
0.22%
0.69%
1.57%
Debt
Debt current
1,422,761
1,647,883
1,417,247
Long-term debt
1,957,274
1,563,367
1,690,558
Deferred revenue
203,714
160,390
109,690
Other long-term liabilities
(160,390)
(107,889)
Net debt
1,176,623
954,608
870,858
Cash flow
Cash from operating activities
925,747
786,824
747,906
CAPEX
(528,469)
(418,123)
(388,323)
Cash from investing activities
(640,194)
(412,773)
(681,231)
Cash from financing activities
(304,571)
(219,302)
136,130
FCF
618,384
1,002,121
252,340
Balance
Cash
1,615,208
1,758,360
1,732,664
Long term investments
588,204
498,282
504,283
Excess cash
1,880,262
1,934,941
1,969,109
Stockholders' equity
7,555,020
6,513,169
6,379,605
Invested Capital
8,966,232
7,924,161
7,683,792
ROIC
18.31%
13.56%
9.26%
ROCE
16.57%
12.84%
8.68%
EV
Common stock shares outstanding
2,978,999
2,985,389
3,031,547
Price
4.94
14.62%
4.31
7.21%
4.02
-6.94%
Market cap
14,716,255
14.37%
12,867,027
5.58%
12,186,819
-7.26%
EV
16,229,036
14,153,859
13,331,522
EBITDA
2,205,807
1,639,174
1,229,916
EV/EBITDA
7.36
8.63
10.84
Interest
125,413
90,905
65,630
Interest/NOPBT
6.97%
7.17%
7.81%